Healthcare provider profile · identity verified

Paul Aguillon, M.D.

Family Practice · BLADES, DE · NPI 1275813552

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	449	126
Lisinopril	Lisinopril	316	79
Losartan Potassium	Losartan Potassium	256	67
Amlodipine Besylate	Amlodipine Besylate	251	69
Omeprazole	Omeprazole	233	65
Metformin Hcl	Metformin Hcl	209	51
Gabapentin	Gabapentin	203	49
Tamsulosin Hcl	Tamsulosin Hcl	192	46
Levothyroxine Sodium	Levothyroxine Sodium	173	48
Azithromycin	Azithromycin	157	106
Hydrochlorothiazide	Hydrochlorothiazide	154	44
Trazodone Hcl	Trazodone Hcl	132	38
Prednisone	Prednisone	124	49
Metformin Hcl Er	Metformin Hcl	121	32
Famotidine	Famotidine	116	32
Alprazolam	Alprazolam	110	20
Pantoprazole Sodium	Pantoprazole Sodium	109	28
Furosemide	Furosemide	102	34
Albuterol Sulfate Hfa	Albuterol Sulfate	94	31
Fluticasone Propionate	Fluticasone Propionate	89	32
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	88	67
Metoprolol Tartrate	Metoprolol Tartrate	84	22
Ibuprofen	Ibuprofen	83	25
Tramadol Hcl	Tramadol Hcl	83	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	36
Eliquis	Apixaban	77	19
Metoprolol Succinate	Metoprolol Succinate	77	25
Glimepiride	Glimepiride	75	19
Rosuvastatin Calcium	Rosuvastatin Calcium	70	23
Escitalopram Oxalate	Escitalopram Oxalate	65	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	18
Carvedilol	Carvedilol	61	17
Clopidogrel	Clopidogrel Bisulfate	61	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	17
Cephalexin	Cephalexin	59	38
Hydroxyzine Hcl	Hydroxyzine Hcl	55	15
Simvastatin	Simvastatin	55	15
Montelukast Sodium	Montelukast Sodium	53	14
Pravastatin Sodium	Pravastatin Sodium	53	15
Fluoxetine Hcl	Fluoxetine Hcl	49	11
Jardiance	Empagliflozin	49	17
Bupropion Hcl Sr	Bupropion Hcl	47	12
Naproxen	Naproxen	47	29
Clonazepam	Clonazepam	46	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	45	suppressed
Ezetimibe	Ezetimibe	43	suppressed
Farxiga	Dapagliflozin Propanediol	43	suppressed
Ozempic	Semaglutide	42	12
Fluconazole	Fluconazole	41	27
Allopurinol	Allopurinol	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	14
Finasteride	Finasteride	39	suppressed
Mirtazapine	Mirtazapine	38	11
Amoxicillin	Amoxicillin	37	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Sertraline Hcl	Sertraline Hcl	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	16
Dutasteride	Dutasteride	29	suppressed
Meloxicam	Meloxicam	29	15
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Potassium Chloride	Potassium Chloride	29	12
Tresiba Flextouch U-100	Insulin Degludec	29	suppressed
Meclizine Hcl	Meclizine Hcl	28	17
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Glipizide	Glipizide	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Atenolol	Atenolol	26	suppressed
Doxepin Hcl	Doxepin Hcl	26	12
Lovastatin	Lovastatin	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Colchicine	Colchicine	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	17
Latanoprost	Latanoprost	24	suppressed
Nystatin	Nystatin	24	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	14
Tradjenta	Linagliptin	24	suppressed
Baclofen	Baclofen	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	11
Ondansetron Hcl	Ondansetron Hcl	23	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Topiramate	Topiramate	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Diazepam	Diazepam	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Lorazepam	Lorazepam	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Ssd	Silver Sulfadiazine	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Indomethacin	Indomethacin	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error